Table of Content

Executive Summary
Scope and Definition

1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Companion Diagnostics Market Trend Analysis
1.1.2 Implementation of Liquid Biopsy-Based Companion Diagnostics
1.1.3 Combining Artificial Intelligence and Companion Diagnostics
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Year)
1.4 Regulatory Landscape
1.4.1 Legal Requirements and Framework by the FDA
1.4.2 Legal Requirements and Framework by the EMA
1.4.3 Legal Requirements and Framework by the MHLW
1.5 CDx from a Historical Perspective
1.6 Constituents for Companion Diagnostics (CDx) Development
1.7 Companion Diagnostics (CDx): Future Potential
1.8 Market Dynamics Overview
1.8.1 Market Drivers
1.8.1.1 Rising Prevalence of Cancer Cases
1.8.1.2 Increasing Product Approvals in the Field of Companion Diagnostics
1.8.1.3 Advancing Biomedical Imaging as the Driving Force for Precision Medicine’s Companion Diagnostics
1.8.2 Market Restraints
1.8.2.1 Uncertain Reimbursement Scenario
1.8.2.2 Stringent Regulatory Approval Processes
1.8.3 Market Opportunities
1.8.3.1 Progress in Companion Diagnostics Driven by Continuous Development and Technological Advancements
1.8.3.2 Introduction of Epigenomics-Based Companion Diagnostics

2 Application
2.1 Application Segmentation
2.1.1 Application Summary
2.1.2 End User Summary
2.2 Global Companion Diagnostics Market (by Application)
2.2.1 Lung Cancer
2.2.2 Breast Cancer
2.2.3 Colorectal Cancer
2.2.4 Leukemia
2.2.5 Stomach Cancer
2.2.6 Melanoma
2.2.7 Others
2.3 Global Companion Diagnostics Market (by End User)
2.3.1 Pharmaceutical and Biotechnology Companies
2.3.2 Reference Laboratories
2.3.3 Others

3 Products
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Companion Diagnostics Market (by Technology)
3.3.1 Polymerase Chain Reaction (PCR)
3.3.2 Immunohistochemistry (IHC)
3.3.3 In-Situ Hybridization (ISH)
3.3.4 Next-Generation Sequencing

4 Regions
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 Application
4.3.8 Product
4.3.9 Canada
4.3.10 Application
4.3.11 Product
4.4 Europe
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.4 Application
4.4.5 Product
4.4.6 France
4.4.7 Application
4.4.8 Product
4.4.9 Germany
4.4.10 Application
4.4.11 Product
4.4.12 U.K.
4.4.13 Application
4.4.14 Product
4.4.15 Spain
4.4.16 Application
4.4.17 Product
4.4.18 Italy
4.4.19 Application
4.4.20 Product
4.4.21 Rest-of-Europe
4.4.22 Application
4.4.23 Product
4.5 Asia-Pacific
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.4 Application
4.5.5 Product
4.5.6 China
4.5.7 Application
4.5.8 Product
4.5.9 India
4.5.10 Application
4.5.11 Product
4.5.12 Australia
4.5.13 Application
4.5.14 Product
4.5.15 Japan
4.5.16 Application
4.5.17 Product
4.5.18 South Korea
4.5.19 Application
4.5.20 Product
4.5.21 Rest-of-Asia-Pacific
4.5.22 Application
4.5.23 Product
4.6 Latin America
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.4 Application
4.6.5 Product
4.6.6 Brazil
4.6.7 Application
4.6.8 Product
4.6.9 Mexico
4.6.10 Application
4.6.11 Product
4.6.12 Rest-of-Latin America
4.6.13 Application
4.6.14 Product
4.7 Middle East and Africa
4.7.1 Regional Overview
4.7.2 Driving Factors for Market Growth
4.7.3 Factors Challenging the Market
4.7.4 Application
4.7.5 Product
4.7.1 U.A.E.
4.7.2 Application
4.7.3 Product
4.7.4 South Africa
4.7.5 Application
4.7.6 Product
4.7.7 Rest-of-Middle East and Africa
4.7.8 Application
4.7.9 Product

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers
5.2 Geographic Assessment
5.2.1 Abbott Laboratories
5.2.1.1 Overview
5.2.1.2 Top Products/Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.2 Agilent Technologies, Inc.
5.2.2.1 Overview
5.2.2.2 Top Products/Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.3 Amoy Diagnostics Co., Ltd.
5.2.3.1 Overview
5.2.3.2 Top Products/Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.4 bioM?rieux
5.2.4.1 Overview
5.2.4.2 Top Products
5.2.4.3 Top Competitors
5.2.4.4 Target Customers
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.5 Danaher Corporation
5.2.5.1 Overview
5.2.5.2 Top Products/Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.6 DiaCarta
5.2.6.1 Overview
5.2.6.2 Top Products/Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.7 F. Hoffmann-La Roche Ltd
5.2.7.1 Overview
5.2.7.2 Top Products/Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.8 ICON plc
5.2.8.1 Overview
5.2.8.2 Top Products/Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.9 Illumina, Inc.
5.2.9.1 Overview
5.2.9.2 Top Products/Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.10 Invivoscribe Technologies, Inc.
5.2.10.1 Overview
5.2.10.2 Top Products/Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.11 Myriad Genetics, Inc.
5.2.11.1 Overview
5.2.11.2 Top Products/Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.12 Novogene Co, Ltd.
5.2.12.1 Overview
5.2.12.2 Top Products/Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers
5.2.12.5 Key Personnel
5.2.12.6 Analyst View
5.2.13 QIAGEN N.V.
5.2.13.1 Overview
5.2.13.2 Top Products/Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Target Customers
5.2.13.5 Key Personnel
5.2.13.6 Analyst View
5.2.14 Sysmex Corporation
5.2.14.1 Overview
5.2.14.2 Top Products/Product Portfolio
5.2.14.3 Top Competitors
5.2.14.4 Target Customers
5.2.14.5 Key Personnel
5.2.14.6 Analyst View
5.2.15 Thermo Fisher Scientific Inc.
5.2.15.1 Overview
5.2.15.2 Top Products/Product Portfolio
5.2.15.3 Top Competitors
5.2.15.4 Target Customers
5.2.15.5 Key Personnel
5.2.15.6 Analyst View
6 Research Methodology
6.1 Data Sources
6.1.1 Primary Data Sources
6.1.2 Secondary Data Sources
6.1.3 Data Triangulation
6.2 Market Estimation and Forecast
List of Figures
Figure 1: Global Companion Diagnostics Market, $Million, 2023, 2026, and 2033
Figure 2: Global Companion Diagnostics Market (by Region), $Million, 2022, 2026, and 2033
Figure 3: Global Companion Diagnostics Market (by Application), $Million, 2022, 2026, and 2033
Figure 4: Global Companion Diagnostics Market (by Technology), $Million, 2022, 2026, and 2033
Figure 5: Global Companion Diagnostics Market (by End User), $Million, 2022, 2026, and 2033
Figure 6: Key Players in the Companion Diagnostics Industry
Figure 7: Key Industrial Developments in Global Companion Diagnostics Market, 2023
Figure 8: Key Aspects Related to Liquid Biopsy-Based Companion Diagnostics
Figure 9: Applications of Digital Diagnostics
Figure 10: Supply Chain and Risks within the Supply Chain
Figure 11: Global Companion Diagnostics Market (by Country), January 2021-December 2023
Figure 12: Global Companion Diagnostics (by Year), January 2021-December 2023
Figure 13: Evolution of Companion Diagnostics
Figure 14: Components Required to Develop Companion Diagnostics
Figure 15: Future Prospects of CDx
Figure 16: Impact Analysis of Market Navigating Factors, 2023-2033
Figure 17: Factors Impacting Reimbursement Scenario
Figure 18: Advancements in Companion Diagnostics
Figure 19: Future Outlook of Epigenomics
Figure 20: North America Companion Diagnostics Market, $Million, 2022-2033
Figure 21: U.S. Companion Diagnostics Market, $Million, 2022-2033
Figure 22: Canada Companion Diagnostics Market, $Million, 2022-2033
Figure 23: Europe Companion Diagnostics Market, $Million, 2022-2033
Figure 24: France Companion Diagnostics Market, $Million, 2022-2033
Figure 25: Germany Companion Diagnostics Market, $Million, 2022-2033
Figure 26: U.K. Companion Diagnostics Market, $Million, 2022-2033
Figure 27: Spain Companion Diagnostics Market, $Million, 2022-2033
Figure 28: Italy Companion Diagnostics Market, $Million, 2022-2033
Figure 29: Rest-of-Europe Companion Diagnostics Market, $Million, 2022-2033
Figure 30: Asia-Pacific Companion Diagnostics Market, $Million, 2022-2033
Figure 31: China Companion Diagnostics Market, $Million, 2022-2033
Figure 32: India Companion Diagnostics Market, $Million, 2022-2033
Figure 33: Australia Companion Diagnostics Market, $Million, 2022-2033
Figure 34: Japan Companion Diagnostics Market, $Million, 2022-2033
Figure 35: South Korea Companion Diagnostics Market, $Million, 2022-2033
Figure 36: Rest-of-Asia-Pacific Companion Diagnostics Market, $Million, 2022-2033
Figure 37: Latin America Companion Diagnostics Market, $Million, 2022-2033
Figure 38: Brazil Companion Diagnostics Market, $Million, 2022-2033
Figure 39: Mexico Companion Diagnostics Market, $Million, 2022-2033
Figure 40: Rest-of-Latin America Companion Diagnostics Market, $Million, 2022-2033
Figure 41: Middle East and Africa Companion Diagnostics Market, $Million, 2022-2033
Figure 42: U.A.E. Companion Diagnostics Market, $Million, 2022-2033
Figure 43: South Africa Companion Diagnostics Market, $Million, 2022-2033
Figure 44: Rest-of-Middle East and Africa Companion Diagnostics Market, $Million, 2022-2033
Figure 45: Strategic Initiatives, 2021-2023
Figure 46: Share of Strategic Initiatives, 2021-2023
Figure 47: Data Triangulation
Figure 48: Top-Down and Bottom-Up Approach
Figure 49: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Global Companion Diagnostics Market, Opportunities
Table 3: Some of FDA Approved Liquid Biopsy CDx Tests
Table 4: Cancer Cases Expected between 2020 and 2040
Table 5: Product Approvals in the Field of Companion Diagnostics
Table 6: Global Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 7: Companion Diagnostics Preparation (by Region), $Million, 2022-2033
Table 8: North America Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 9: North America Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 10: North America Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 11: U.S. Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 12: U.S. Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 13: U.S. Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 14: Canada Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 15: Canada Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 16: Canada Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 17: Europe Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 18: Europe Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 19: Europe Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 20: France Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 21: France Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 22: France Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 23: Germany Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 24: Germany Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 25: Germany Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 26: U.K. Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 27: U.K. Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 28: U.K. Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 29: Spain Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 30: Spain Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 31: Spain Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 32: Italy Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 33: Italy Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 34: Italy Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 35: Rest-of-Europe Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 36: Rest-of-Europe Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 37: Rest-of-Europe Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 38: Asia-Pacific Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 39: Asia-Pacific Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 40: Asia-Pacific Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 41: China Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 42: China Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 43: China Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 44: India Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 45: India Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 46: India Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 47: Australia Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 48: Australia Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 49: Australia Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 50: Japan Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 51: Japan Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 52: Japan Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 53: South Korea Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 54: South Korea Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 55: South Korea Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 56: Rest-of-Asia-Pacific Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 57: Rest-of-Asia-Pacific Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 58: Rest-of-Asia-Pacific Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 59: Latin America Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 60: Latin America Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 61: Latin America Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 62: Brazil Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 63: Brazil Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 64: Brazil Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 65: Mexico Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 66: Mexico Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 67: Mexico Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 68: Rest-of-Latin America Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 69: Rest-of-Latin America Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 70: Rest-of-Latin America Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 71: Middle East and Africa Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 72: Middle East and Africa Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 73: Middle East and Africa Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 74: U.A.E. Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 75: U.A.E. Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 76: U.A.E. Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 77: South Africa Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 78: South Africa Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 79: South Africa Companion Diagnostics Market (by Technology), $Million, 2022-2033
Table 80: Rest-of-Middle East and Africa Companion Diagnostics Market (by Application), $Million, 2022-2033
Table 81: Rest-of-Middle East and Africa Companion Diagnostics Market (by End User), $Million, 2022-2033
Table 82: Rest-of-Middle East and Africa Companion Diagnostics Market (by Technology), $Million, 2022-2033